Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 4,345 shares at $11.89 ($52K) on 2026-08-21, disclosed to the SEC on 2026-08-24.
Scheduled sale ($52k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KURA | SELL | 2026-05-20 | $3K | — | Filing → |
| KURA | SELL | 2026-01-27 | $54K | — | Filing → |
| KURA | SELL | 2025-11-14 | $199K | — | Filing → |